Status:
COMPLETED
Nitric Oxide Lung Diffusing Capacity in Healthy, Non-smoking Adults
Lead Sponsor:
University of Zurich
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
The measurement of nitric oxide lung diffusing capacity (DLNO) has been recently standardised. To date, two pulmonary function devices are commercially available and are used for the measurement of DL...
Detailed Description
In a single-center, crossover study conducted at the University Hospital Zurich, Switzerland, 35 healthy, non-smoking adults (\>=18 years) will be invited to perform DLNO measurements in random order ...
Eligibility Criteria
Inclusion
- \- Age 18 years and older
Exclusion
- Previous thoracic surgery
- Smoking
- Chronic lung disease (e.g., asthma bronchiale, COPD)
- Forced expiratory volume in 1s and/or forced vital capacity below the lower limit of normal based on spirometry \[Quanjer et al. Eur Respir J 2005\]
- Current respiratory infection
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04016597
Start Date
October 1 2019
End Date
January 31 2020
Last Update
February 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Zurich and University Hospital of Zurich
Zurich, Switzerland, 8001